Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C

American Journal of Ophthalmology
T J HeigleD A Palay

Abstract

To study the effect of topical mitomycin C on conjunctival squamous neoplasia. Three patients with recurrent conjunctival epithelial neoplasia were treated with topical mitomycin C 0.04%. Six to 9 months after treatment, no patient had clinical evidence of tumor recurrence. Conjunctival biopsy in two patients and cytology in one patient showed no evidence of tumor 1 to 4 months after treatment. One patient required short-term treatment for corneal edema and epithelial toxicity. Topical mitomycin C caused tumor regression without recurrence for 6 to 9 months after treatment.

References

May 1, 1990·Archives of Ophthalmology·T H Mader, R D Stulting
May 1, 1995·Survey of Ophthalmology·G A Lee, L W Hirst
Feb 15, 1994·American Journal of Ophthalmology·J Frucht-Pery, Y Rozenman
Jan 24, 1998·American Journal of Ophthalmology·M W WilsonS A Madreperla

❮ Previous
Next ❯

Citations

Mar 29, 2001·Survey of Ophthalmology·M W WilsonB G Haik
Mar 5, 2002·Ophthalmology·Joseph Frucht-PeryJacob Pe'er
Jul 12, 2008·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M SchallenbergD Meller
Feb 5, 2008·American Journal of Ophthalmology·Anita PandaShalini Mohan
Nov 30, 1999·American Journal of Ophthalmology·A S HawkinsJ B Rubenstein
May 7, 2002·American Journal of Ophthalmology·Carol L ShieldsJerry A Shields
Jul 15, 2009·Clinical & Experimental Ophthalmology·Adam K Rudkin, James S Muecke
Dec 22, 2006·Expert Opinion on Drug Safety·Ali A Mearza, Ioannis M Aslanides
Aug 17, 2006·Seminars in Ophthalmology·Antony M Poothullil, Kathryn A Colby
Mar 22, 2005·Cornea·Donald U StoneJames Chodosh
Aug 18, 2004·Journal of Cataract and Refractive Surgery·Shu-Wen Chang
Jan 24, 1998·American Journal of Ophthalmology·H E Grossniklaus, T M Aaberg
Sep 26, 2003·Cornea·Surendra Basti, Marian S Macsai
Mar 12, 2002·Clinical & Experimental Ophthalmology·Mark DaniellDerek Tole
Aug 21, 2012·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Sean Paul, Donald U Stone
Jul 21, 2009·Ophthalmic Plastic and Reconstructive Surgery·Priscilla L BallalaiJeison N Barros
May 22, 2010·Ophthalmic Plastic and Reconstructive Surgery·Riad N Ma'luf
Jan 7, 2009·International Ophthalmology Clinics·Rola HamamCharles Stephen Foster
Dec 2, 2014·International Ophthalmology Clinics·Jacob Pe'er
Feb 27, 2003·Cornea·Teresa Rodríguez-AresCarmen Capeans
Sep 28, 2002·Cornea·Andreas A PapandroudisNikolaos T Stangos
Jul 29, 2010·Ocular Immunology and Inflammation·Carol L KarpSonia H Yoo
Apr 12, 2017·Asia-Pacific Journal of Ophthalmology·Edoardo MidenaRaffaele Parrozzani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.